Market cap:
$9.87B+$282.16M(+2.94%)Summary
- As of today (April 16, 2025), NBIX market capitalization is $9.87 billion, with a rise of +$282.16 million (+2.94%) during the current trading session.
- Over the past year, NBIX market cap has dropped by -$3.51 billion (-26.22%).
- NBIX market cap is now -36.94% below its all-time high of $15.65 billion.
Performance
NBIX Market cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Related metrics
Market cap Formula
Market Cap = Price ✕ Shares Outstanding
NBIX Market cap Trends
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | Enterprise valueEnterprise value |
|---|---|---|---|---|
| todaytoday | +2.9% | +2.9% | +0.3% | +2.9% |
| 1 m1 month | -10.7% | -10.6% | - | -10.4% |
| 3 m3 months | -30.0% | -30.3% | - | -29.6% |
| 6 m6 months | -17.6% | -16.4% | - | -15.1% |
| ytdytd | -26.5% | -27.5% | - | -26.0% |
| 1 y1 year | -26.2% | -25.6% | -0.9% | -25.2% |
| 5 y5 years | +11.7% | +4.0% | +7.4% | +10.3% |
NBIX Market cap Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | $11.58B | -14.8% | $8.73B | +13.1% |
| 3 m | 3-month | $15.36B | -35.8% | $8.73B | +13.1% |
| 6 m | 6-month | $15.36B | -35.8% | $8.73B | +13.1% |
| 1 y | 1-year | $15.65B | -36.9% | $8.73B | +13.1% |
| 3 y | 3-year | $15.65B | -36.9% | $7.24B | +36.3% |
| 5 y | 5-year | $15.65B | -36.9% | $6.88B | +43.5% |
| alltime | all time | $15.65B | -36.9% | $72.58M | >+9999.0% |
Neurocrine Biosciences Market cap History
| Date | Value |
|---|---|
| 2025 | $9.87B(-26.5%) |
| 2024 | $13.42B(+2.5%) |
| 2023 | $13.10B(+13.6%) |
| 2022 | $11.53B(+42.6%) |
| 2021 | $8.08B(-9.8%) |
| 2020 | $8.96B(-9.6%) |
| 2019 | $9.92B(+53.0%) |
| 2018 | $6.48B(-5.9%) |
| 2017 | $6.89B(+104.9%) |
| 2016 | $3.36B(-31.1%) |
| 2015 | $4.88B(+185.7%) |
| 2014 | $1.71B(+171.6%) |
| 2013 | $629.06M(+26.6%) |
| 2012 | $497.02M(+5.8%) |
| 2011 | $469.73M(+12.0%) |
| Date | Value |
|---|---|
| 2010 | $419.30M(+250.4%) |
| 2009 | $119.66M(-3.1%) |
| 2008 | $123.51M(-28.9%) |
| 2007 | $173.76M(-56.0%) |
| 2006 | $394.98M(-83.0%) |
| 2005 | $2.33B(+29.3%) |
| 2004 | $1.80B(-6.5%) |
| 2003 | $1.93B(+37.6%) |
| 2002 | $1.40B(-10.1%) |
| 2001 | $1.56B(+85.7%) |
| 2000 | $838.54M(+56.8%) |
| 1999 | $534.80M(+310.9%) |
| 1998 | $130.15M(-6.6%) |
| 1997 | $139.29M(-24.2%) |
| 1996 | $183.70M |
FAQ
- What is Neurocrine Biosciences market capitalization?
- What is the all time high market cap for Neurocrine Biosciences?
- What is NBIX market capitalization year-to-date change?
- What is Neurocrine Biosciences market cap year-on-year change?
What is Neurocrine Biosciences market capitalization?
The current market cap of NBIX is $9.87B
What is the all time high market cap for Neurocrine Biosciences?
Neurocrine Biosciences all-time high market capitalization is $15.65B
What is NBIX market capitalization year-to-date change?
Neurocrine Biosciences market capitalization has changed by -$3.55B (-26.47%) since the beginning of the year
What is Neurocrine Biosciences market cap year-on-year change?
Over the past year, NBIX market capitalization has changed by -$3.51B (-26.22%)